Emerging oral immunomodulating agents – focus on teriflunomide for the treatment of multiple sclerosis

Nwankwo E, Allington DR, Rivey MP

Degenerative Neurological and Neuromuscular Disease 2012, 2:15-28

Published Date: 13 March 2012